[1]任衍乔,郑传胜.肝癌射频消融术后各种影像学评价应用与进展 [J].介入放射学杂志,2018,27(10):993-996.
　REN Yanqiao,ZHENG Chuansheng..Different imaging assessments for hepatocellular carcinoma after radiofrequency ablation： clinical application and recent progress[J].journal interventional radiology,2018,27(10):993-996.
点击复制

肝癌射频消融术后各种影像学评价应用与进展 

()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
27
期数:
2018年10期
页码:
993-996
栏目:
综述
出版日期:
2018-10-25

文章信息/Info

Title:
Different imaging assessments for hepatocellular carcinoma after radiofrequency ablation： clinical application and recent progress
作者:
任衍乔;  郑传胜
Author(s):
REN Yanqiao;  ZHENG Chuansheng.
Department of Radiology， Affiliated Union Hospital， Tongji Medical College， Huazhong University of Science and Technology， Wuhan， Hubei Province 430022， China
关键词:
【关键词】 肝癌;  射频消融;  影像学评价;  综述
文献标志码:
A
摘要:
【摘要】 射频消融（RFA）已成为无法外科手术切除的肝细胞肝癌（HCC）和结直肠肝转移癌行之有效的治疗手段，具有微创、疗效满意、术后恢复快、节省治疗费用等优点，但仍存在部分肿瘤残存和复发问题，一定程度上影响了治疗肝癌效果。因此，RFA术后影像学检查及时发现残存和复发肿瘤，利于提高患者生存期和生活质量。该文就超声、CT、MRI、PET- CT、PET- MR在肝癌RFA术后评价中应用与进展作一综述。

参考文献/References:

［1］ Riccardo L， Laura C. Local- regional treatment of hepatocellular carcinoma［J］. Radiology， 2012， 262： 43- 58.
［2］ 翁高龙， 黄建国， 褚 丹， 等． 超声造影引导射频消融治疗等回声肝癌的临床应用［J］． 介入放射学杂志， 2014， 23： 922- 925．
［3］ Peng ZW， Lin XJ， Zhang YJ， et al. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller： a retrospective comparative study［J］. Radiology， 2012， 262： 1022- 1033.
［4］ McLoney ED， Isaacson AJ， Keating P. The role of PET imaging before， during， and after percutaneous hepatic and pulmonary tumor ablation［J］. Semin Intervent Radiol， 2014， 31： 187- 192.
［5］ Choi D， Lim HK， Lee WJ， et al. Radiofrequency ablation of liver cancer： early evaluation of therapeutic response with contrast- enhanced ultrasonography［J］. Korean J Radiol， 2004， 5： 185- 198.
［6］ Choi D， Lim HK， Kim SH， et al. Hepatocellular carcinoma treated with percutaneous radio- frequency ablation： usefulnessof power Doppler US with a microbubble contrast agent inevaluating therapeutic response- preliminary results［J］. Radiology， 2000， 217： 558- 563.
［7］ Kim SK， Lim HK， Kim YH， et al. Hepatocellular carcinoma treated with radio- frequency ablation： spectrum of imaging findings［J］. Radiographics， 2003， 23： 107- 121.
［8］ Solbiati L， Goldberg SN， Ierace T， et al. Radio- frequency ablation of hepatic metastases： postprocedural assessment with a US microbubble contrast agent： early experience［J］. Radiology， 1999， 211： 643- 649.
［9］ Wang XY， Chen D， Zhang XS， et al. Value of F- 18- FDG- PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation： a comparative study with contrast- enhanced ultrasound［J］. J Dig Dis， 2013， 14： 433- 438.
［10］ Catala V， Nicolau C， Vilana R， et al. Characterization of focal liver lesions： comparative study of contrast- enhanced ultrasound versus spiral computed tomography［J］. Eur Radiol， 2007， 17： 1066- 1073.
［11］ Bo XW， Xu HX， Sun LP， et al. Bipolar radiofrequency ablation for liver tumors： comparison of contrast- enhanced ultrasound with contrast- enhanced MRI/CT in the posttreatment imaging evaluation［J］. Int J Clin Exp Pathol， 2014， 7： 6108- 6116.
［12］ Frieser M， Kiesel J， Lindner A， et al. Efficacy of contrast- enhanced US versus CT or MRI for the therapeutic control of percutaneous radiofrequency ablation in the case of hepatic malignancies［J］. Ultraschall Med， 2011， 32： 148- 153.
［13］ Luo W， Numata K， Morimoto M， et al. Role of sonazoid- enhanced three- dimensional ultrasonography in the evaluation of percutaneous radiofrequency ablation of hepatocellular carcinoma［J］. Eur J Radiol， 2010， 75： 91- 97.
［14］ 陈露阳， 廖锦堂， 齐文君， 等． 动态三维超声造影评价肝癌射频消融术疗效的价值［J］． 中华医学超声杂志?电子版， 2017， 14： 193- 199．
［15］ 杜丹丹， 吕维富． 肝癌射频消融后的影像学评价［J］． 介入放射学杂志， 2012， 21： 75- 78．
［16］ Morimoto M， Sugimori K， Shirato K， et al. Treatment of hepatocellular carcinoma with radiofrequency ablation： radiologic- histologic correlation during follow- up periods［J］. Hepatology， 2002， 35： 1467- 1475.
［17］ Meijerink MR， van Waesberghe JH， van der Weide L， et al. Early detection of local RFA site recurrence using total liver volume perfusion CT initial experience［J］. Acad Radiol， 2009， 16： 1215- 1222.
［18］ Dromain C， de Baere T， Elias D， et al. Hepatic tumors treated with percutaneous radio- frequency ablation： CT and MR imaging follow- up［J］. Radiology， 2002， 223： 255- 262.
［19］ Thieme SF， Vahldiek JL， Tummler K， et al. Value or waste： perfusion imaging following radiofrequency ablation- early experience［J］. Clin Hemorheol Microcirc， 2015， 61： 323- 331.
［20］ Marquez HP， Puippe G， Mathew RP， et al. CT perfusion for early response evaluation of radiofrequency ablation of focal liver lesions： first experience［J］. Cardiovasc Intervent Radiol， 2017， 40： 90- 98.
［21］ Sainani NI， Gervais DA， Mueller PR. Imaging after percutaneous radiofrequency ablation of hepatic tumors： part 2， abnormal findings［J］. AJR Am J Roentgenol， 2013， 200： 194- 204.
［22］ Hwang J， Kim SH， Kim YS， et al. Gadoxetic acid- enhanced MRI versus multiphase multidetector row computed tomography for evaluating the viable tumor of hepatocellular carcinomas treated with image- guided tumor therapy［J］. J Magn Reson Imaging， 2010， 32： 629- 638.
［23］ Puls R， Kroncke TJ， Kluner C， et al. Double contrast MRI of thermally ablated liver metastases［J］. Rofo， 2003， 175： 1467- 1470.
［24］ Liu Y， Lu L， Jin H， et al. Radiofrequency ablation of liver VX2 tumor： experimental results with MR diffusion- weighted imaging at 3.0T［J］. PLoS One， 2014， 9： e104239.
［25］ 钟丽云， 蒋天安， 赵齐羽， 等． 影像融合超声造影技术对常规超声及超声造影显示不清肝癌的诊治价值［J］． 中华超声影像学杂志， 2015， 24： 963- 967．
［26］ 朱金彪， 黄 枢． 融合成像磁导航系统在肝癌局部消融中应用［J］． 临床军医杂志， 2016， 44： 213- 215．
［27］ 陈嘉欣， 许尓蛟， 李 凯， 等． CT/MRI- CEUS 影像融合在原发性肝癌消融治疗中的临床价值［J］． 中华肝脏外科手术学电子杂志， 2015， 4： 352- 356．
［28］ 董 怡， 王文平． 多种影像学新技术评估肝癌射频消融术后疗效［J］． 中华超声影像学杂志， 2013， 22： 910- 912．
［29］ Vogt FM， Antoch G， Veit P， et al. Morphologic and functional changes in nontumorous liver tissue after radiofrequency ablation in an in vivo model： comparison of F- 18- FDG PET/CT， MRI， ultrasound， and CT［J］. J Nucl Med， 2007， 48： 1836- 1844.
［30］ Anderson GS， Brinkmann F， Soulen MC， et al. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation［J］. Clin Nucl Med， 2003， 28： 192- 197.
［31］ Pichler BJ， Kolb A， Nagele T， et al. PET/MRI： paving the way for the next generation of clinical multimodality imaging applications［J］. J Nucl Med， 2010， 51： 333- 336.
［32］ Nielsen K， Scheffer HJ， Pieters IC， et al. The use of PET- MRI in the follow- up after radiofrequency- and microwave ablation of colorectal liver metastases［J］. BMC Med Imaging， 2014， 14： 27.
［33］ Beiderwellen K， Gomez B， Buchbender C， et al. Depiction and characterization of liver lesions in whole body 18F- FDG PET/MRI［J］. Eur J Radiol， 2013， 82： e669- e675.
［34］ Warner E. Intensive radiologic surveillance： a focus on the psychological issues［J］. Ann Oncol， 2004， 15： I43- I47.

相似文献/References:

[1]蒲红.上海市第二届射频消融疑难病例研讨会纪要[J].介入放射学杂志,1997,(01):63.
[2]蒲红,尹炯,王咏梅,等.显性间隔房室旁路的射频消融[J].介入放射学杂志,1997,(02):104.
[3]罗荣光,黄金华.肿瘤射频消融：电极的类型和消融灶的特点[J].介入放射学杂志,2011,(02):159.
　LUO Rong-guang,HUANG Jin-hua..Radiofrequency ablation of tumors: the relationship between the electrode type and the feature of ablated zone[J].journal interventional radiology,2011,(10):159.
[4]朱先海,吕维富,鲁 东,等.超选择性肾动脉栓塞术联合射频消融治疗肾癌的临床应用[J].介入放射学杂志,2011,(07):541.
　ZHU Xian-hai,LV Wei-fu,LU Dong,et al.Superselective renal artery embolization combined with radiofrequency ablation for the treatment of renal carcinomas: evaluation of clinical results[J].journal interventional radiology,2011,(10):541.
[5]谢小西,吕银祥,章宏欣,等. 肝动脉化疗栓塞、射频消融联合１２５Ⅰ粒子植入 治疗原发性肝癌的临床应用[J].介入放射学杂志,2011,(11):863.
　XIE Xiao-xi,LV Yin-xiang,ZHANG Hong-xin,et al.The clinical application of TACE together with RFA and 125Ⅰ seed implantation in treating hepatocellular carcinoma[J].journal interventional radiology,2011,(10):863.
[6]张　　　磊,陆骊工,李　　　勇,等.门静脉支架联合肝动脉化疗栓塞治疗肝癌伴门静脉癌栓的临床研究[J].介入放射学杂志,2011,(12):968.
　ZHANG Lei,LU Li-gong,LI Yong,et al.Portal vein stent placement combined with TACE for the treatment of hepatocellular carcinoma associated with tumor thrombus in portal vein[J].journal interventional radiology,2011,(10):968.
[7]李建军,郑加生,崔雄伟,等. 肝肿瘤CT引导经皮射频消融术后胆道并发症防治[J].介入放射学杂志,2011,(12):984.
　LI Jian-jun,ZHENG Jia-sheng,CUI Xiong-wei,et al.The prevention and treatment of biliary complications occurred after CT-guided percutaneous radiofrequency ablation for hepatic neoplasms[J].journal interventional radiology,2011,(10):984.
[8]敖 劲,张跃伟,徐 克. 明胶海绵微粒经动脉栓塞治疗原发性肝癌的研究现状[J].介入放射学杂志,2011,(12):1010.
　AO Jin,ZHANG Yue-wei,XU Ke..Gelatin sponge particle used as an embolic agent in transcatheter arterial chemoembolization treatment for primary hepatocellular carcinoma: its current situation in research[J].journal interventional radiology,2011,(10):1010.
[9]杜丹丹,吕维富. 肝癌射频消融后的影像学评价[J].介入放射学杂志,2012,(01):75.
　DU Dan dan,Lv Wei fu..Imaging evaluation of liver cancer after radiofrequency ablation therapy[J].journal interventional radiology,2012,(10):75.
[10]赵 艳,韩国宏,白 苇,等. 药物缓释微球肝动脉化疗栓塞治疗肝癌研究进展[J].介入放射学杂志,2012,(01):78.
　ZHAO Yan,HAN Guo-hong,BAI Wei,et al.Transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma: its research progress[J].journal interventional radiology,2012,(10):78.
[11]帕哈尔丁·白克热,杨树法,黄伍奎,等.肝动脉化疗栓塞联合射频消融术治疗３０例原发性大肝癌的疗效评价[J].介入放射学杂志,2012,(04):322.
　,,et al.ＴＡＣＥ ｃｏｍｂｉｎｅｄ ｗｉｔｈ ｒａｄｉｏｆｒｅｑｕｅｎｃｙ ａｂｌａｔｉｏｎ ｆｏｒ ｍａｓｓｉｖｅ ｐｒｉｍａｒｙ ｈｅｐａｔｏｃｅｌｌｕｌａｒ ｃａｒｃｉｎｏｍａｓ： ａ ｃｌｉｎｉｃａｌ ｔｈｅｒａｐｅｕｔｉｃ ｅｖａｌｕａｔｉｏｎ [J].journal interventional radiology,2012,(10):322.
[12]彭国文,李晓群. 射频消融及组合方案治疗特殊/高危部位肝癌的中远期疗效[J].介入放射学杂志,2013,(06):525.
　PENG Guo? wen,LI Xiao? qun.. The mid?蛳 to?蛳 long term efficacy of radiofrequency ablation together with combination regimen for the treatment of hepatic carcinomas located at special or high?蛳 risk regions[J].journal interventional radiology,2013,(10):525.
[13]管清龙,任伟新,纪卫政.肝癌治疗后血清内血管内皮生长因子对预后影响的研究进展[J].介入放射学杂志,2013,(08):701.
　GUAN Qing? long,REN Wei? xin,JI Wei? zheng..The impact of serum vascular endothelial growth factor expression on the prognosis in patients with hepatocellular carcinoma after treatment： recent progress in clinical research[J].journal interventional radiology,2013,(10):701.
[14]陈付文,郑春生,黄柿兵,等.肝动脉化疗栓塞联合射频消融治疗大肝癌的临床观察[J].介入放射学杂志,2015,(08):684.
　CHEN Fu- wen,ZHENG Chun- sheng,HUANG Shi- bing,et al.TACE combined with RFA for the treatment of massive primary hepatocellular carcinomas： observation of clinical efficacy and safety[J].journal interventional radiology,2015,(10):684.
[15]付静静,王 凇,杨 薇.射频消融联合肝动脉化疗栓塞治疗肝癌的应用[J].介入放射学杂志,2016,(03):268.
　FU Jing- jing,WANG Song,YANG Wei.Clinical application of radiofrequency ablation combined with transcatheter arterial chemoembolization for the treatment of liver cancer [J].journal interventional radiology,2016,(10):268.
[16]黄职妹,宁额尔敦巴格,李 慧,等.CT引导下人工腹水结合三维可视化系统辅助射频消治疗难消融复发性肝癌 [J].介入放射学杂志,2022,31(04):387.
　HUANG Zhimei,NING Eerdunbage,LI Hui,et al.CT-guided artificial ascites combined with three-dimensional visualization system-assisted radiofrequency ablation for refractory recurrent hepatocellular carcinoma[J].journal interventional radiology,2022,31(10):387.

备注/Memo

备注/Memo:
（收稿日期：２０１7-12-18）
（本文编辑：边 佶）
更新日期/Last Update: 2018-10-15